Polylite Taiwan (1813) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 寶利徠

Polylite Taiwan (1813) reported revenue of NT$21.9 million for Oct 2026, +0.6% year on year and -2.0% from the previous month. Revenue for Jan–Oct 2026 was NT$237.5 million (-7.2% year on year).

In Oct 2026, it ranked No. 122 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$24.8 million24/10Nov 2024 NT$25 millionDec 2024 NT$22.9 millionJan 2025 NT$23.1 millionFeb 2025 NT$29.7 million25/02Mar 2025 NT$30.9 millionApr 2025 NT$26.7 millionMay 2025 NT$28.4 millionJun 2025 NT$25.5 million25/06Jul 2025 NT$23.3 millionAug 2025 NT$22.6 millionSep 2025 NT$24 millionOct 2025 NT$21.8 million25/10Nov 2025 NT$20.4 millionDec 2025 NT$27.8 millionJan 2026 NT$28.1 millionFeb 2026 NT$19 million26/02Mar 2026 NT$26.7 millionApr 2026 NT$26.6 millionMay 2026 NT$25.4 millionJun 2026 NT$21.9 million26/06Jul 2026 NT$22.8 millionAug 2026 NT$22.7 millionSep 2026 NT$22.4 millionOct 2026 NT$21.9 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$21.9 million+0.6%-2.0%
Sep 2026NT$22.4 million-6.9%-1.6%
Aug 2026NT$22.7 million+0.6%-0.3%
Jul 2026NT$22.8 million-2.2%+4.1%
Jun 2026NT$21.9 million-14.4%-13.9%
May 2026NT$25.4 million-10.4%-4.6%
Apr 2026NT$26.6 million-0.3%-0.4%
Mar 2026NT$26.7 million-13.6%+41.1%
Feb 2026NT$19 million-36.2%-32.6%
Jan 2026NT$28.1 million+21.9%+1.0%
Dec 2025NT$27.8 million+21.7%+36.2%
Nov 2025NT$20.4 million-18.2%-6.2%
Oct 2025NT$21.8 million-12.0%-9.3%
Sep 2025NT$24 million-6.1%+6.4%
Aug 2025NT$22.6 million+0.2%-3.0%
Jul 2025NT$23.3 million-19.4%-8.8%
Jun 2025NT$25.5 million+25.3%-10.0%
May 2025NT$28.4 million-5.6%+6.2%
Apr 2025NT$26.7 million-11.6%-13.7%
Mar 2025NT$30.9 million+20.5%+4.1%
Feb 2025NT$29.7 million+18.8%+28.9%
Jan 2025NT$23.1 million-20.2%+0.9%
Dec 2024NT$22.9 million-6.4%-8.4%
Nov 2024NT$25 million-8.9%+0.9%
Oct 2024NT$24.8 million-19.7%-3.3%

Jan–Oct 2026 cumulative: NT$237.5 million (-7.2% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Polylite Taiwan vs PEC / Polylite Taiwan vs Lotus Pharm / Polylite Taiwan vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16